Atopic Hand and Foot Dermatitis
Dermatology
Prevalence
5562.5 / 100K
Incidence
8261.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Lebrikizumab | ELI LILLY & Co (LLY) |
Frequently asked questions
How many drugs are in development for Atopic Hand and Foot Dermatitis?
BioSniper tracks 1 drug in development for Atopic Hand and Foot Dermatitis across 1 company.
How many clinical trials target Atopic Hand and Foot Dermatitis?
There are 1 clinical trial targeting Atopic Hand and Foot Dermatitis tracked by BioSniper.
What is the prevalence of Atopic Hand and Foot Dermatitis?
The estimated prevalence of Atopic Hand and Foot Dermatitis is approximately 5562.5 per 100,000 population.
Deep-dive into Atopic Hand and Foot Dermatitis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis